These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1778190)

  • 1. Attenuation of nitrate effect during an intermittent treatment regimen and the time course of nitrate tolerance.
    James MA; Papouchado M; Jones JV
    Eur Heart J; 1991 Dec; 12(12):1266-72. PubMed ID: 1778190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
    Parker JD; Parker AB; Farrell B; Parker JO
    Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
    Freedman SB; Daxini BV; Noyce D; Kelly DT
    J Am Coll Cardiol; 1995 Feb; 25(2):349-55. PubMed ID: 7829787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators.
    Fox KM; Dargie HJ; Deanfield J; Maseri A
    Br Heart J; 1991 Aug; 66(2):151-5. PubMed ID: 1909152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina.
    Gumbrielle T; Freedman SB; Fogarty L; Ogasawara S; Sobb P; Kelly DT
    Eur Heart J; 1992 May; 13(5):671-8. PubMed ID: 1618212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.
    Parker JO; Amies MH; Hawkinson RW; Heilman JM; Hougham AJ; Vollmer MC; Wilson RR
    Circulation; 1995 Mar; 91(5):1368-74. PubMed ID: 7867175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal nitroglycerin in angina pectoris.
    Abrams J
    Eur Heart J; 1989 May; 10 Suppl A():11-9. PubMed ID: 2501090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin.
    Nabel EG; Barry J; Rocco MB; Mead K; Selwyn AP
    Am J Cardiol; 1989 Mar; 63(11):663-9. PubMed ID: 2493732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval.
    Schaer DH; Buff LA; Katz RJ
    Am J Cardiol; 1988 Jan; 61(1):46-50. PubMed ID: 3122549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical benefit of transdermal glyceryl trinitrate when used with an eight hour patch-free period.
    Whalley DW; Hellestrand KJ
    Aust N Z J Med; 1990 Oct; 20(5):677-81. PubMed ID: 2126727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.
    DeMots H; Glasser SP
    J Am Coll Cardiol; 1989 Mar; 13(4):786-95. PubMed ID: 2494240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intermittent (eight hours off) transdermal nitrate therapy in stable angina.
    Akhras F; Hellestrand K; Whalley D; Jackson G
    Int J Cardiol; 1994 Mar; 43(3):251-6. PubMed ID: 8181883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of tolerance to nitroglycerin patches by overnight removal.
    Cowan JC; Bourke JP; Reid DS; Julian DG
    Am J Cardiol; 1987 Aug; 60(4):271-5. PubMed ID: 3113223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy.
    Parker JO; Parker JD; Caldwell RW; Farrell B; Kaesemeyer WH
    J Am Coll Cardiol; 2002 Apr; 39(7):1199-203. PubMed ID: 11923046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?
    Rudolph W; Dirschinger J; Reiniger G; Beyerle A; Hall D
    Eur Heart J; 1988 Jan; 9 Suppl A():63-72. PubMed ID: 3137072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule.
    Ferratini M; Pirelli S; Merlini P; Silva P; Pollavini G
    Eur Heart J; 1989 Nov; 10(11):998-1002. PubMed ID: 2512162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application.
    Luke R; Sharpe N; Coxon R
    J Am Coll Cardiol; 1987 Sep; 10(3):642-6. PubMed ID: 3114351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.
    Todd PA; Goa KL; Langtry HD
    Drugs; 1990 Dec; 40(6):880-902. PubMed ID: 2127741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent or continuous transdermal nitroglycerin: still an issue, or is the case closed?
    Klemsdal TO; Gjesdal K
    Cardiovasc Drugs Ther; 1996 Mar; 10(1):5-10. PubMed ID: 8723164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker.
    Holdright DR; Katz RJ; Wright CA; Sparrow JL; Sullivan AK; Cunningham AD; Fox KM
    Br Heart J; 1993 Mar; 69(3):223-7. PubMed ID: 8096389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.